Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
复制标题

DOI:
10.1038/ajg.2013.160
复制
发表时间:
2013-08
影响因子:
9.8
通讯作者:
McGlynn, Katherine A.
McGlynn, Katherine A.
中科院分区:
医学1区
文献类型:
--
作者:
Welzel, Tania M.;Graubard, Barry I.;Quraishi, Sabah;Zeuzem, Stefan;Davila, Jessica A.;El-Serag, Hashem B.;McGlynn, Katherine A.

文献摘要

参考文献

被引文献

相似文献

肝细胞癌(HCC)的风险因素包括B和C型肝炎病毒(HBV、HCV)、过量饮酒、罕见遗传疾病和糖尿病/肥胖。然而,这些因素的人群归因分数(PAF)尚未在美国的基于人群的研究中进行研究。1994年至2007年期间诊断为HCC的≥ 68岁患者(n = 6,991)在SEER-Medicare数据库中确定。选择居住在SEER地点的5%随机样本(n = 255,702)进行比较。对于每个风险因素,计算比值比(OR)、95%置信区间(95% CI)和PAF。正如预期的那样,HCC的风险增加与以下每个因素有关:(OR 39.89,95% CI:36.29-43.84),HBV(OR 11.17,95% CI:9.18-13.59),酒精相关疾病(OR 4.06,95% CI:3.82-4.32)、罕见代谢紊乱(OR 3.45,95% CI:2.97-4.02)和糖尿病和/或肥胖(OR 2.47,95% CI:2.34-2.61)。所有因素合并的PAF为64.5%(男性65.6%;女性62.2%)。PAF在亚洲人中最高(70.1%),在黑人中最低(52.4%)。在个体因素中,糖尿病/肥胖具有最大的PAF(36.6%),其次是酒精相关疾病(23.5%)、HCV(22.4%)、HBV(6.3%)和罕见遗传疾病(3.2%)。虽然糖尿病/肥胖在男性(36.4%)和女性(36.7%)中具有最大的PAF,但酒精相关疾病在男性(27.8%)中具有第二大PAF,HCV在女性中具有第二大PAF(28.1%)。糖尿病/肥胖在白人(38.9%)和西班牙裔(38.1%)中具有最大的PAF,而HCV在亚洲人(35.4%)和黑人(34.9%)中具有最大的PAF。第二大PAF是白人(25.6%)、西班牙裔(30.1%)和黑人(18.5%)的酒精相关疾病,以及亚洲人(28.5%)的HBV。美国≥68岁人群中HCC的主要风险因素因性别和人种/种族而异。总的来说,消除糖尿病/肥胖可以降低HCC的发病率,而不是消除任何其他因素。
Risk factors for hepatocellular carcinoma (HCC) include hepatitis B and C viruses (HBV, HCV), excessive alcohol consumption, rare genetic disorders and diabetes/obesity. The population attributable fractions (PAF) of these factors, however, have not been investigated in population-based studies in the United States. Persons ≥ 68 years diagnosed with HCC (n = 6,991) between 1994 and 2007 were identified in the SEER-Medicare database. A 5 % random sample (n = 255,702) of persons residing in SEER locations were selected for comparison. For each risk factor, odds ratios (ORs), 95 % confidence intervals (95 % CI) and PAFs were calculated. As anticipated, the risk of HCC was increased in relationship to each factor: HCV (OR 39.89, 95 % CI: 36.29–43.84), HBV (OR 11.17, 95 % CI: 9.18–13.59), alcohol-related disorders (OR 4.06, 95 % CI: 3.82–4.32), rare metabolic disorders (OR 3.45, 95 % CI: 2.97–4.02), and diabetes and/or obesity (OR 2.47, 95 % CI: 2.34–2.61). The PAF of all factors combined was 64.5 % (males 65.6 % ; females 62.2 %). The PAF was highest among Asians (70.1 %) and lowest among black persons (52.4 %). Among individual factors, diabetes/obesity had the greatest PAF (36.6 %), followed by alcohol-related disorders (23.5 %), HCV (22.4 %), HBV (6.3 %) and rare genetic disorders (3.2 %). While diabetes/obesity had the greatest PAF among both males (36.4 %) and females (36.7 %), alcohol-related disorders had the second greatest PAF among males (27.8 %) and HCV the second greatest among females (28.1 %). Diabetes/obesity had the greatest PAF among whites (38.9 %) and Hispanics (38.1 %), while HCV had the greatest PAF among Asians (35.4 %) and blacks (34.9 %). The second greatest PAF was alcohol-related disorders in whites (25.6 %), Hispanics (30.1 %) and blacks (and 18.5 %) and HBV in Asians (28.5 %). The dominant risk factors for HCC in the United States among persons ≥68 years differ by sex and race/ethnicity. Overall, eliminating diabetes/obesity could reduce the incidence of HCC more than the elimination of any other factor.
DOI: 10.1136/bmj.d1584
发表时间: 2011-04-07
期刊: BMJ (Clinical research ed.)
影响因子: --
作者:
Schütze M;Boeing H;Pischon T;Rehm J;Kehoe T;Gmel G;Olsen A;Tjønneland AM;Dahm CC;Overvad K;Clavel-Chapelon F;Boutron-Ruault MC;Trichopoulou A;Benetou V;Zylis D;Kaaks R;Rohrmann S;Palli D;Berrino F;Tumino R;Vineis P;Rodríguez L;Agudo A;Sánchez MJ;Dorronsoro M;Chirlaque MD;Barricarte A;Peeters PH;van Gils CH;Khaw KT;Wareham N;Allen NE;Key TJ;Boffetta P;Slimani N;Jenab M;Romaguera D;Wark PA;Riboli E;Bergmann MM
通讯作者: Bergmann MM
DOI: 10.1016/s0959-8049(96)00500-x
发表时间: 1997-04-01
影响因子: 8.4
作者:
Braga, C;LaVecchia, C;Franceschi, S
通讯作者: Franceschi, S
DOI: 10.1093/oxfordjournals.aje.a121617
发表时间: 1974-01-01
影响因子: 5
作者:
MIETTINE.OS
通讯作者: MIETTINE.OS
DOI: 10.2105/ajph.94.11.1952
发表时间: 2004-11-01
影响因子: 12.7
作者:
McQuillan, GM;Kruszon-Moran, D;Kington, RS
通讯作者: Kington, RS
DOI: 10.1002/hep.510260308
发表时间: 1997-09-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Donato, F;Tagger, A;Nardi, G
通讯作者: Nardi, G